Other Clients/Companies To Watch:

Access Pharmaceuticals, Inc
(OTC: ACCP)

Alexza Pharmaceuticals, Inc.
(NASDAQ:ALXA)

Crucell N.V.
(Euronext, NASDAQ: CRXL)

DelSite Biotechnologies, Inc.
(OTC: DSII)

Digital Angel Corporation
(AMEX:DOC)

Duska Therapeutics, Inc.
(OTC:DSKA)

Elan Corporation
(NYSE: ELN)

Galapagos NV
(Euronext:GLPGA)

Intercell AG
(VSE:ICLL)

KERYX Biopharmaceuticals, Inc.
(NASDAQ:KERX)

Lpath, Inc.
(OTC:LPTN)

Manhattan Pharmaceuticals, Inc.
(AMEX:MHA)

Mediware Information Systems, Inc. (NASDAQ: MEDW)

Pipex Pharmaceuticals, Inc.
(OTC:PPXP.OB)

Quidel
(NASDAQ:QDEL)

Redpoint Bio Corporation
(OTC:RPBC)

XTLbio
(NASDAQ:XTLB)

VIA Pharmaceuticals, Inc.
(NASDAQ: VIAP)

ZIOPHARM, INC.
(NASDAQ:ZIOP)

Dr. Carlton E. Turner - CEO

Carrington Laboratories, Inc., is an ISO-certified, research-based biopharmaceutical and consumer products company currently utilizing naturally occurring complex carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care as well as to manufacture and market the nutraceutical raw materials Manapol® and Hydrapol(TM). Carrington Laboratories also manufactures and markets consumer products sold under its AloeCeuticals® brand and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. More than 120 patents in 26 countries protect Carrington Laboratories' technology. Select products are honored with the internationally coveted CE mark, recognized by more than 20 countries around the world.

COMPANY NEWS | COMPANY WEBSITE |SEC FILINGS | STOCK QUOTE